Related Experiment Video
Updated: Jul 6, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Effect of statins on the development of renal dysfunction
Rishi Sukhija1, Zoran Bursac, Priyanka Kakar
1Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System and the University of Arkansas for Medical Sciences, Little Rock, AR, USA.
The American Journal of Cardiology
|March 25, 2008
Summary
Statins may slow the progression of kidney dysfunction, even without lowering cholesterol. This study found statin use reduced the odds of developing renal dysfunction by 13% in a large patient cohort.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Dyslipidemia is a known risk factor for renal dysfunction.
- Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) are commonly prescribed to lower cholesterol.
- The potential renoprotective effects of statins warrant investigation.
Purpose of the Study:
- To investigate the association between statin use and the development of renal dysfunction.
- To determine if statins offer protection against kidney disease progression, independent of their lipid-lowering effects.
Main Methods:
- A retrospective analysis of 197,551 patients from the Department of Veterans Affairs VISN16 database.
- Patients were categorized into statin users (29.5%) and non-users (70.5%).
- Renal dysfunction was defined as a doubling of baseline creatinine or an increase of ≥0.5 mg/dl over a minimum of 90 days.
Main Results:
- Over 3.1 years, 3.4% of patients developed renal dysfunction.
- Statin use was associated with a 13% decreased odds of developing renal dysfunction (OR 0.87, 95% CI 0.82 to 0.92, p <0.0001) after adjusting for covariates.
- The protective effect of statins was independent of cholesterol reduction.
- Age, diabetes, hypertension, and smoking were significant risk factors for renal dysfunction.
Conclusions:
- Statin therapy may play a role in retarding the development of renal dysfunction.
- The renoprotective benefits of statins appear to be independent of their cholesterol-lowering properties.
- Further research is needed to elucidate the mechanisms behind statins' potential renal benefits.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:17Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...